Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal

Behavioural Pharmacology

Volumn 6, Issue 1, 1995, Pages 74-80

  Heinrichs, S C ^a   Menzaghi, F ^a   Schulteis, G ^a   Koob, G F ^a   Stinus, L ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

Central nucleus of amygdala; CRF; Operant suppression; Opiate; Place conditioning; Rat; Taste aversion; Withdrawal

Indexed keywords

17 METHYLNALOXONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR ANTIBODY; CORTICOTROPIN RELEASING FACTOR[9-41]; LITHIUM; MONENSIN; MONOCLONAL ANTIBODY; MORPHINE; NALOXONE; RICIN A; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSIVE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORPHINE ADDICTION; MOTIVATION; NONHUMAN; PLACE PREFERENCE; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TASTE AVERSION; WITHDRAWAL SYNDROME;

EID: 0028860024     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199501000-00011     Document Type: Article

References (0)